← 產業報告目錄
Ticagrelor Market, By Strength (60 mg, and 90 mg), By Indication (Acute Coronary Syndrome, and Ischemic Stroke), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
出版商 Coherent Market Insights出版日期 2026-07-17頁數 258報告編號 CMR-2a20fac461
授權報價
| Single User Price | $4,500 USD |
| Site License Price | $7,000 USD |
| Enterprisewide Price (Global Site License) | $10,000 USD |
報告摘要
Ticagrelor, a drug commonly used as a platelet aggregation inhibitor, received approval from U.S. Food and Drug Administration (USFDA) in July 2011 and in the European Union by the European Commission in December, 2010. Ticagrelor is used for the prevention of thrombotic events such as stroke or heart attack in people with acute coronary syndrome or myocardial infarction with ST wave elevation.
Market Dynamics
Rising prevalence of cardiovascular diseases is attributed to rising geriatric population and changing lifestyles. According to World Health Organization (WHO), around 17.9 million people every year die due to cardiovascular diseases (CVDs), which is about 31% of all global deaths. This is expected to positively impact growth of the ticagrelor market over the next decade.
Furthermore, in September 2016, WHO launched the Global Hearts Initiative through which WHO is supporting governments around the world to improve efforts on CVD prevention and control. Thus, increasing number of non-government and government initiatives, in order to aid in prevention of CVD is expected to help in propelling growth of the ticagrelor market over the forecast period.
Key features of the study
• This report provides in-depth analysis of the ticagrelor market, market size (US$ Bn) and cumulative annual growth rate (CAGR (%)) for the forecast period: 2026 – 2033, considering 2025, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global ticagrelor market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include C.H. Boehringer Sohn AG & Ko. KG, Pfizer Inc., Eli Lilly and Company, AstraZeneca plc, Natco Pharma Limited, ANHUI HAIKANG PHARMACEUTICAL CO., LTD., Avra Laboratories Pvt Ltd., and Sun Pharmaceutical Industries Ltd
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global ticagrelor market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for ticagrelor market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• By Strength (Revenue, USD Bn, 2021-2033)
o 60 mg
o 90 mg
• By Indication (Revenue, USD Bn, 2021-2033)
o Acute Coronary Syndrome
o Ischemic Stroke
• By Distribution Channel (Revenue, USD Bn, 2021-2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o C.H. Boehringer Sohn AG & Ko. KG
o Pfizer Inc.
o Eli Lilly and Company
o AstraZeneca plc
o Natco Pharma Limited
o Anhui Haikang Pharmaceutical Co., Ltd.
o Avra Laboratories Pvt. Ltd.
o Sun Pharmaceutical Industries Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Strength
Market Snippet, By Indication
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Pipeline Analysis
o Historical Overview
o Merger and Acquisition
o Regulatory Scenario
o PORTER’S Five Forces
o PEST Analysis
4. Global Ticagrelor Market, By Strength, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o 60 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o 90 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Ticagrelor Market, By Indication, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Acute Coronary Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Ischemic Stroke
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Ticagrelor Market, By Distribution Channel, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022-2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Ticagrelor Market, By Regions, 2021-2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, By Region, 2022-2033
Regional Trends
o North America
Market Size and Forecast, By Strength, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Strength, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Strength, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
Market Size and Forecast, By Strength, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Strength, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
o Middle East
Market Size and Forecast, By Strength, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
C.H. Boehringer Sohn AG & Ko. KG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
AstraZeneca plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Natco Pharma Limited
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
ANHUI HAIKANG PHARMACEUTICAL CO., LTD.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Avra Laboratories Pvt. Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
Sun Pharmaceutical Industries Ltd
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About us and Sales Contact
圖表清單 List of Tables & Figures
NA
NA
提及公司
o C.H. Boehringer Sohn AG & Ko. KGo Pfizer Inc.o Eli Lilly and Companyo AstraZeneca plco Natco Pharma Limitedo Anhui Haikang Pharmaceutical Co.Ltd.o Avra Laboratories Pvt. Ltd.o Sun Pharmaceutical Industries Ltd.
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們